SCHEMBL18563422

SCHEMBL18563422

CC(=O)COc1ccc(-c2cccc([C@@H](C)O)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.49
▸ PTPN5 P54829 1/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ LMNA P02545 2/20 0.45
▸ RXRA P19793 1/20 0.44
▸ RXRB P28702 1/20 0.44
▸ RXRG P48443 1/20 0.44
▸ CTSA P10619 1/20 0.44
▸ NPC1 O15118 3/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ APP P05067 1/20 0.42
▸ CASP3 P42574 1/20 0.42
▸ SENP8 Q96LD8 1/20 0.42
▸ SENP7 Q9BQF6 1/20 0.42
▸ SENP6 Q9GZR1 1/20 0.42
▸ FFAR4 Q5NUL3 1/20 0.41
▸ ADRB2 P07550 2/20 0.41
▸ ADRB3 P13945 2/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15447650 0.89 MAPT (0.52) MAPTPTPN5SMN1; SMN2LMNARXRA
SCHEMBL17299140 0.89 MAPT (0.52) MAPTPTPN5SMN1; SMN2LMNARXRA
SCHEMBL17299139 0.84 KDM4E (0.53) MAPTNPC1RAB9A
SCHEMBL15447648 0.84 KDM4E (0.53) MAPTNPC1RAB9A
SCHEMBL8264165 0.80 PPARG (0.51) MAPTSMN1; SMN2LMNANPC1RAB9A
SCHEMBL18563474 0.79 GAA (0.53) MAPTPTPN5LMNARXRARXRB
SCHEMBL7733929 0.78 MAPT (0.66) MAPTSMN1; SMN2LMNANPC1RAB9A
SCHEMBL15447676 0.76 CYP1A2 (0.69) MAPTPTPN5RXRARXRBRXRG
SCHEMBL15447706 0.76 CYP1A2 (0.69) MAPTPTPN5RXRARXRBRXRG
SCHEMBL17299142 0.76 CYP1A2 (0.69) MAPTPTPN5RXRARXRBRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2861604-B1 MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES GILEAD SCIENCES INC (US) 2017-03-01 — — EP disclosed
Send feedback